Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021)
Elicio Therapeutics posted quarterly Gross Profit of $24.7 million for Q4 2021, up 1149.36% year-on-year from $2.0 million in Q4 2020, and up 1591.92% on a QoQ basis from $1.5 million in Q3 2021.
Elicio Therapeutics (ELTX) has 2 years of Gross Profit data on file, last reported at $24.7 million in Q4 2021.
- For the quarter ending Q4 2021, Gross Profit rose 1149.36% year-over-year to $24.7 million; the trailing twelve-month figure through Dec 2021 stood at $27.1 million (up 1553.97% YoY), and the FY2022 full-year result was $2.3 million, down 91.5% from the prior year.
- Gross Profit for Q4 2021 stood at $24.7 million, up from $1.5 million in the prior quarter.
- Across five years, Gross Profit topped out at $24.7 million in Q4 2021 and bottomed at -$2.4 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 24.70 Mn |
| Dec 31, 2021 | 24.70 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 540,000.00 |
| Jun 30, 2021 | 540,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Dec 31, 2020 | -2.35 Mn |
| Dec 31, 2020 | -2.35 Mn |
| Sep 30, 2020 | 479,000.00 |
| Sep 30, 2020 | 479,000.00 |
| Jun 30, 2020 | 396,000.00 |
| Jun 30, 2020 | 396,000.00 |
| Mar 31, 2020 | -383,000.00 |
| Mar 31, 2020 | -383,000.00 |